Introduction: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare genetic cause of renal impairment resulting from mutations in the MUC1, UMOD, HNF1B, REN, and SEC61A1 genes. Neither the national or global prevalence of these diseases has been determined. We aimed to establish a database of patients with ADTKD in Ireland and report the clinical and genetic characteristics of these families. Methods: We identified patients via the Irish Kidney Gene Project and referral to the national renal genetics clinic in Beaumont Hospital who met the clinical criteria for ADTKD (chronic kidney disease, bland urinary sediment, and autosomal dominant inheritance). Eligible patients were then invited to undergo genetic testing by a variety of methods including panel-based testing, whole exome sequencing and, in five families who met the criteria for diagnosis of ADTKD but were negative for causal genetic mutations, we analyzed urinary cell smears for the presence of MUC1fs protein. Results: We studied 54 individuals from 16 families. We identified mutations in the MUC1 gene in three families, UMOD in five families, HNF1beta in two families, and the presence of abnormal MUC1 protein in urine smears in three families (one of which was previously known to carry the genetic mutation). We were unable to identify a mutation in 4 families (3 of whom also tested negative for urinary MUC1fs). Conclusions: There are 4443 people with ESRD in Ireland, 24 of whom are members of the cohort described herein. We observe that ADTKD represents at least 0.54% of Irish ESRD patients.

Clinical Research Centre Royal College of Surgeons Dublin Ireland

Department of Medicine Boston Children's Hospital Harvard Medical School Boston MA USA

Department of Medicine Royal College of Surgeons Dublin Ireland

Department of Pediatrics and Adolescent Medicine Research Unit for Rare Diseases 1st Faculty of Medicine Charles University Prague Czech Republic

Nephrology Department Beaumont Hospital Dublin Ireland

Pathology Department Beaumont Hospital Dublin Ireland

Section on Nephrology Wake Forest School of Medicine Winston Salem NC USA

Trinity Health Kidney Centre Tallaght Hospital Dublin Ireland

Trinity Health Kidney Centre Trinity Translational Medicine Institute Dublin Ireland

Zobrazit více v PubMed

Bleyer AJ, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: of names and genes. Kidney Int. 2014;86:459–461. PubMed

Faguer S, Decramer S, Chassaing N, et al. . Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int. 2011;80:768–776. PubMed

Medicine M-N. Online Mendelian inheritance in man. An online catalog of human genes and genetic disorders [Website]. John Hopkins University: OMIM; 2018 [updated 2018 Sep 7]. Available from: https://www.omim.org.

Bolar NA, Golzio C, Živná M, et al. . Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia. Am J Hum Genet. 2016;99:174–187. PubMed PMC

Bleyer AJ, Kmoch S, Antignac C, et al. . Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol. 2014;9:527–535. PubMed PMC

Bollée G, Dahan K, Flamant M, et al. . Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clin J Am Soc Nephrol. 2011;6:2429–2438. PubMed PMC

Eckardt KU, Alper SL, Antignac C, et al. . Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management – a KDIGO consensus report. Kidney Int. 2015;88:676–683. PubMed

Kirby A, Gnirke A, Jaffe DB, et al. . Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45:299–303. PubMed PMC

Yamamoto S, Kaimori JY, Yoshimura T, et al. . Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein. Nephrol Dial Transplant. 2017;32:2010–2017. PubMed

Živná M, Kidd K, Přistoupilová A, et al. . Noninvasive immunohistochemical diagnosis and novel MUC1 mutations causing autosomal dominant tubulointerstitial kidney disease. J Am Soc Nephrol. 2018;29:2418–2431. PubMed PMC

Blumenstiel B, DeFelice M, Birsoy O, et al. . Development and validation of a mass spectrometry–based assay for the molecular diagnosis of mucin-1 kidney disease. J Mol Diagn. 2016;18:566–571. PubMed

Musetti C, Babu D, Fusco I, et al. . Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease. J Nephrol. 2016;29:451–455. PubMed

Gale DP, Kleta R. MUC1 makes me miserable. J Am Soc Nephrol. 2018;29:2257. PubMed PMC

Stack AG, Casserly LF, Cronin CJ, et al. . Prevalence and variation of chronic kidney disease in the Irish health system: initial findings from the National Kidney Disease Surveillance Programme. BMC Nephrol. 2014;15. DOI:10.1186/1471-2369-15-185. PubMed DOI PMC

Plant L. editor Epidemiology of ESKD in Ireland. Irish Nephrology Society Annual Meeting. Kildare (Ireland): Carton House; 2018.

Green A, Allos M, Donohoe J, et al. . Prevalence of hereditary renal disease. Ir Med J. 1990;83:11–13. PubMed

Connaughton DM, Bukhari S, Conlon P, et al. . The Irish Kidney Gene Project – prevalence of family history in patients with kidney disease in Ireland. Nephron. 2015;130:293–301. PubMed

Connaughton DM, Kennedy C, Shril S, et al. . Monogenic causes of chronic kidney disease in adults. Kidney Int. 2019;95:914–928. PubMed PMC

Bleyer AJ Jr, Hart PS, Kmoch S Autosomal dominant tubulointerstitial kidney disease, UMOD-Related Seattle: University of Washington; 2007 [updated 2016; cited 2018 July 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1356/.

Mann N, Braun DA, Amann K, et al. . Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. J Am Soc Nephrol. 2019;30:201–215. PubMed PMC

Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760. PubMed PMC

McKenna A, Hanna M, Banks E, et al. . The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–1303. PubMed PMC

Duitama J, Quintero JC, Cruz DF, et al. . An integrated framework for discovery and genotyping of genomic variants from high-throughput sequencing experiments. Nucleic Acids Res. 2014;42:e44. PubMed PMC

Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. PubMed PMC

Richards S, Aziz N, Bale S, et al. . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. PubMed PMC

Calado J, Gaspar A, Clemente C, et al. . A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy. BMC Med Genet. 2005;6:5. PubMed PMC

Lee DH, Kim JK, Oh SE, et al. . A case of familial juvenile hyperuricemic nephropathy with novel uromodulin gene mutation, a novel heterozygous missense mutation in Korea. J Korean Med Sci. 2010;25:1680–1682. PubMed PMC

Zaucke F, Boehnlein JM, Steffens S, et al. . Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. Human Mol Genet. 2010;19:1985–1997. PubMed PMC

Scolari F, Caridi G, Rampoldi L, et al. . Uromodulin storage diseases: clinical aspects and mechanisms. Am J Kidney Dis. 2004;44:987–999. PubMed

Lhotta K, Piret SE, Kramar R, et al. . Epidemiology of uromodulin-associated kidney disease – results from a nation-wide survey. Nephron Extra. 2012;2:147–158. PubMed PMC

Ayasreh N, Bullich G, Miquel R, et al. . Autosomal dominant tubulointerstitial kidney disease: clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1. Am J Kidney Dis. 2018;72:411–418. PubMed

Gast C, Marinaki A, Arenas-Hernandez M, et al. . Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC Nephrol. 2018;19:301. PubMed PMC

Gillespie BW, Morgenstern H, Hedgeman E, et al. . Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J. 2015;8:772–780. PubMed PMC

Soloukides AP, Moutzouris DAD, Papagregoriou GN, et al. . Renal graft outcome in autosomal dominant medullary cystic kidney disease type 1. J Nephrol. 2013;26:793–798. PubMed

Autosomal dominant tubulointerstitial kidney disease: A review

The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project